R27	Appositive Attribute:T401 Head:T91
R28	Appositive Attribute:T423 Head:T114
R29	Appositive Attribute:T439 Head:T152
R30	Appositive Attribute:T440 Head:T152
R31	PredicateNominative Attribute:T387 Head:T175
R32	PredicateNominative Attribute:T413 Head:T178
R33	Anaphora Anaphor:T337 Antecedent:T172
R34	Anaphora Anaphor:T380 Antecedent:T5
R35	Anaphora Anaphor:T380 Antecedent:T6
R36	Anaphora Anaphor:T391 Antecedent:T392
R37	Anaphora Anaphor:T410 Antecedent:T408
R38	Anaphora Anaphor:T421 Antecedent:T114
T3	Drug 4300 4314	Cyclosporine A
T4	Drug 4332 4341	Glyburide
T11	Drug 4790 4804	cyclosporine A
T12	Drug 4874 4882	bosentan
T15	Drug 4914 4922	Tracleer
T16	Drug 4927 4941	cyclosporine A
T18	Drug 5095 5104	glyburide
T19	Drug 5124 5132	bosentan
T22	Drug 5164 5173	glyburide
T23	Drug 5178 5186	Tracleer
T28	Drug 11221 11229	Tracleer
T27	Drug_Class 11196 11219	Hormonal contraceptives
T32	Drug 11302 11313	Simvastatin
T33	Drug_Class 11324 11349	CYP3A-metabolized statins
T36	Drug 11426 11434	Rifampin
T35	Drug 11443 11451	bosentan
T38	Drug_Class 11755 11771	CYP2C9 inhibitor
T51	Drug 12037 12045	bosentan
T39	Drug_Class 11814 11836	strong CYP3A inhibitor
T40	Drug_Class 11877 11901	moderate CYP3A inhibitor
T49	Drug 11964 11972	Tracleer
T41	Drug 11781 11792	fluconazole
T42	Drug 11796 11806	amiodarone
T43	Drug 11844 11856	ketoconazole
T44	Drug 11858 11870	itraconazole
T45	Drug 11909 11919	amprenavir
T46	Drug 11921 11933	erythromycin
T47	Drug 11935 11946	fluconazole
T48	Drug 11948 11957	diltiazem
T53	Drug_Class 12124 12148	moderate CYP3A inhibitor
T52	Drug_Class 12090 12106	CYP2C9 inhibitor
T55	Drug 12154 12162	Tracleer
T54	Drug_Class 12114 12120;12133 12148	strong CYP3A inhibitor
T58	Drug 12328 12336	Tracleer
T59	Drug_Class 12265 12304	drugs metabolized by these two isozymes
T61	Substance 12219 12225	CYP2C9
T63	Drug_Class 12615 12638	Hormonal contraceptives
T68	Drug 12729 12737	Tracleer
T64	Drug_Class 12650 12654;12697 12702	oral forms
T65	Drug_Class 12656 12666;12697 12702	injectable forms
T66	Drug_Class 12668 12679;12697 12702	transdermal forms
T67	Drug_Class 12685 12702	implantable forms
T70	Drug_Class 12833 12855	hormonal contraception
T71	Drug 12874 12882	Tracleer
T72	Drug 12986 12994	bosentan
T76	Drug 13071 13084	norethindrone
T74	Drug 13089 13106	ethinyl estradiol
T73	Drug 13001 13040	combination oral hormonal contraceptive
T78	Drug 13297 13305	Tracleer
T79	Drug 13310 13326	cyclosporine A i
T83	Drug 13450 13458	bosentan
T86	Drug 13727 13741	cyclosporine A
T85	Drug 13648 13656	bosentan
T89	Drug 13763 13771	bosentan
T88	Drug 13998 14007	glyburide
T91	Drug 13811 13825	cyclosporine A
T92	Drug_Class 13829 13844	CYP3A substrate
T94	Drug 14067 14076	glyburide
T93	Drug 14054 14062	Tracleer
T98	Drug 14203 14211	bosentan
T99	Drug 14251 14260	glyburide
T101	Drug 14312 14320	bosentan
T102	Drug 14363 14370	Traclee
T104	Drug_Class 14430 14508	oral hypoglycemic agents that are predominantly metabolized by CYP2C9 or CYP3A
T107	Drug 15036 15055	lopinavir/ritonavir
T109	Drug 15118 15126	bosentan
T106	Drug 15004 15012	Tracleer
T111	Drug 15286 15294	Tracleer
T112	Drug 15311 15330	lopinavir/ritonavir
T113	Drug_Class 15631 15646	CYP3A substrate
T114	Drug 15616 15627	simvastatin
T117	Drug_Class 15840 15891	statins that are significantly metabolized by CYP3A
T119	Drug 15773 15781	Tracleer
T120	Drug 15901 15911	lovastatin
T121	Drug 15916 15928	atorvastatin
T127	Drug 16083 16091	Tracleer
T124	Drug_Class 16010 16035	CYP3A-metabolized statins
T132	Drug 16202 16210	rifampin
T129	Drug 16270 16278	bosentan
T131	Drug 16402 16410	bosentan
T134	Drug 16449 16457	Tracleer
T135	Drug 16461 16469	rifampin
T139	Drug 16813 16823	tacrolimus
T137	Drug 16893 16901	bosentan
T142	Drug 16960 16970	Tracleer a
T141	Drug 16945 16955	tacrolimus
T143	Drug_Class 17075 17097	potent CYP3A inhibitor
T144	Drug 17059 17071	ketoconazole
T146	Drug 17138 17146	bosentan
T148	Drug 17263 17271	Tracleer
T153	Drug 17470 17480	R-warfarin
T154	Drug 17330 17338	bosentan
T152	Drug 17434 17444	S-warfarin
T150	Drug_Class 17448 17464	CYP2C9 substrate
T151	Drug_Class 17482 17499	a CYP3A substrate
T157	Drug 18297 18307	sildenafil
T160	Drug 18222 18230	bosentan
T159	Drug 18259 18269	sildenafil
T158	Drug 18351 18359	bosentan
T161	Substance 14775 14791	CYP3A and CYP2C9
T162	Drug 4754 4768	Cyclosporine A
T163	Drug 13247 13261	Cyclosporine A
T164	Drug_Class 2996 3019	Hormonal contraceptives
T165	Drug_Class 12590 12613	Hormonal Contraceptives
T166	Drug 14572 14584	these agents
T167	Drug 17935 17942	Digoxin
T168	Drug 18032 18039	digoxin
T169	Drug 15517 15528	Simvastatin
T170	Drug 47 55	bosentan
T171	Drug 4809 4817	bosentan
T172	Drug 5324 5332	bosentan
T173	Drug 11575 11583	Bosentan
T174	Drug 11689 11697	bosentan
T175	Drug 12183 12191	Bosentan
T176	Drug 12356 12364	Bosentan
T177	Drug 13592 13600	bosentan
T178	Drug 14704 14712	bosentan
T179	Drug 14909 14917	bosentan
T180	Drug 15387 15395	bosentan
T181	Drug 15568 15576	bosentan
T182	Drug 15745 15753	bosentan
T183	Drug 16189 16197	bosentan
T184	Drug 16828 16836	bosentan
T185	Drug 17027 17035	bosentan
T186	Drug 17970 17978	Bosentan
T187	Drug 18115 18123	bosentan
T188	Drug 18745 18753	bosentan
T189	Drug 26 34	Tracleer
T190	Drug 171 179	Tracleer
T191	Drug 238 246	Tracleer
T192	Drug 301 309	Tracleer
T193	Drug 368 376	Tracleer
T194	Drug 521 529	Tracleer
T195	Drug 1124 1132	Tracleer
T196	Drug 1260 1268	Tracleer
T197	Drug 1560 1568	Tracleer
T198	Drug 1744 1752	Tracleer
T199	Drug 1970 1978	Tracleer
T200	Drug 2368 2376	Tracleer
T201	Drug 2446 2454	Tracleer
T202	Drug 2494 2502	Tracleer
T203	Drug 2703 2711	Tracleer
T204	Drug 2767 2775	Tracleer
T205	Drug 3204 3212	Tracleer
T206	Drug 3387 3395	Tracleer
T207	Drug 3467 3475	Tracleer
T208	Drug 3621 3629	Tracleer
T209	Drug 3742 3750	Tracleer
T210	Drug 3923 3931	Tracleer
T211	Drug 4226 4234	Tracleer
T212	Drug 4397 4405	Tracleer
T213	Drug 4619 4627	Tracleer
T214	Drug 5258 5266	Tracleer
T215	Drug 5776 5784	Tracleer
T216	Drug 6054 6062	Tracleer
T217	Drug 6550 6558	Tracleer
T218	Drug 6779 6787	Tracleer
T219	Drug 7068 7076	Tracleer
T220	Drug 7257 7265	Tracleer
T221	Drug 7534 7542	Tracleer
T222	Drug 7602 7610	Tracleer
T223	Drug 7669 7677	Tracleer
T224	Drug 7724 7732	Tracleer
T225	Drug 7879 7887	Tracleer
T226	Drug 7939 7947	Tracleer
T227	Drug 8351 8359	Tracleer
T228	Drug 8526 8534	Tracleer
T229	Drug 8640 8648	Tracleer
T230	Drug 8768 8776	Tracleer
T231	Drug 8877 8885	Tracleer
T232	Drug 9281 9289	Tracleer
T233	Drug 9361 9369	Tracleer
T234	Drug 9641 9649	Tracleer
T235	Drug 9934 9942	Tracleer
T236	Drug 10030 10038	Tracleer
T237	Drug 10268 10276	Tracleer
T238	Drug 10394 10402	Tracleer
T239	Drug 10439 10447	Tracleer
T240	Drug 10659 10667	Tracleer
T241	Drug 12483 12491	Tracleer
T242	Drug 15227 15235	Tracleer
T243	Drug 16752 16760	Tracleer
T244	Drug 17215 17223	Tracleer
T245	Drug 17585 17593	Tracleer
T246	Drug 17889 17897	Tracleer
T247	Drug 13621 13633	cyclosporine
T248	Drug 16159 16167	Rifampin
T249	Drug 16363 16371	rifampin
T250	Drug 14622 14631	Ritonavir
T251	Drug 14641 14650	Ritonavir
T252	Drug 14793 14802	Ritonavir
T253	Drug 14872 14881	ritonavir
T254	Drug 15478 15487	ritonavir
T255	Drug 17960 17968	Losartan
T256	Drug 18060 18068	losartan
T257	Drug 17300 17308	Warfarin
T258	Drug 17598 17606	warfarin
T259	Drug 17707 17715	warfarin
T260	Drug 17792 17800	warfarin
T261	Drug_Class 9689 9697	diuretic
T262	Drug 11703 11715	ketoconazole
T263	Drug 16993 17005	Ketoconazole
T264	Drug 5004 5013	Glyburide
T265	Drug 13873 13882	Glyburide
T266	Drug 18131 18141	Sildenafil
T267	Drug 18543 18553	sildenafil
T268	Drug 16705 16715	Tacrolimus
T269	Drug 16737 16747	tacrolimus
T270	Drug_Class 15539 15546	Statins
T271	Drug 713 718	cases
T272	Drug 1029 1034	cases
T273	Drug 1278 1283	cases
T5	Substance 11602 11608	CYP2C9
T6	Substance 11613 11618	CYP3A
T7	Substance 12209 12214	CYP3A
T9	Substance 12428 12434	CYP1A2
T10	Substance 12436 12442	CYP2C9
T13	Substance 12444 12451	CYP2C19
T14	Substance 12453 12459	CYP2D6
T17	Substance 12461 12466	CYP3A
T453	SPAN 7888 7892	REMS
T297	ZeroArticleNP 0 10	Drug Label
T298	ZeroArticleNP 15 34	drug brand Tracleer
T299	DefiniteNP 124 133	the risks
T300	DefiniteNP 234 261	the Tracleer Access Program
T301	IndefiniteNP 206 226	a restricted program
T302	DefiniteNP 297 325	the Tracleer Risk Evaluation
T303	IndefiniteNP 282 293	a component
T304	DefiniteNP 364 381	the Tracleer REMS
T305	DefiniteNP 436 447	the program
T306	IndefiniteNP 695 709	a small number
T307	IndefiniteNP 746 754	a marker
T308	DemonstrativeNP 728 741	these changes
T309	DefiniteNP 962 986	the postmarketing period
T310	DefiniteNP 991 1002	the setting
T311	ZeroArticleNP 1088 1118	prolonged ( 12 months) therapy
T312	ZeroArticleNP 1177 1191	drug therapies
T313	DefiniteNP 1240 1256	The contribution
T314	DemonstrativeNP 1272 1283	these cases
T315	DefiniteNP 1329 1353	the initial presentation
T316	DefiniteNP 1591 1605	the importance
T317	DefiniteNP 1629 1660	the monthly monitoring schedule
T318	DefiniteNP 1665 1677	the duration
T319	DefiniteNP 1695 1718	the treatment algorithm
T320	IndefiniteNP 1758 1764	a rise
T321	DemonstrativeNP 1570 1579	This case
T322	DefiniteNP 2424 2442	the reintroduction
T323	DemonstrativeNP 2458 2477	these circumstances
T324	DefiniteNP 2675 2684	the start
T325	DefiniteNP 2865 2876	the patient
T326	IndefiniteNP 2881 2902	a tubal sterilization
T327	DefiniteNP 3115 3129	the sole means
T328	ZeroArticleNP 3217 3234	Drug Interactions
T329	DefiniteNP 3463 3490	the Tracleer Access Program
T330	IndefiniteNP 3422 3455	a restricted distribution program
T331	DemonstrativeNP 3511 3522	these risks
T332	ZeroArticleNP 4680 4697	Drug Interactions
T333	ZeroArticleNP 4965 4982	Drug Interactions
T334	IndefiniteNP 5015 5032	An increased risk
T335	ZeroArticleNP 5036 5059	liver enzyme elevations
T336	ZeroArticleNP 5210 5227	Drug Interactions
T337	DefiniteNP 5353 5364	the product
T338	IndefiniteNP 5336 5349	any component
T339	DefiniteNP 5716 5729	the diagnosis
T340	DefiniteNP 6560 6575	The combination
T341	IndefiniteNP 6691 6699	a marker
T342	ZeroArticleNP 7179 7186	therapy
T343	DefiniteNP 7555 7564	the risks
T344	DefiniteNP 7665 7692	the Tracleer Access Program
T345	DefiniteNP 7720 7737	the Tracleer REMS
T346	DefiniteNP 7792 7803	the program
T347	IndefiniteNP 7637 7657	a restricted program
T348	IndefiniteNP 7705 7716	a component
T349	DefiniteNP 7875 7887	the Tracleer
T350	ZeroArticleNP 7861 7871	components
T351	DefiniteNP 7960 7974	the prescriber
T352	PossessivePronoun 8031 8047	its requirements
T353	DefiniteNP 8253 8264	the patient
T354	DemonstrativeNP 8172 8183	these tests
T355	PossessivePronoun 8481 8497	their prescriber
T356	DefiniteNP 8390 8399	the risks
T357	IndefiniteNP 8361 8373	all patients
T358	IndefiniteNP 8423 8448	a patient enrollment form
T359	DefiniteNP 8550 8561	the program
T360	DefiniteNP 8587 8597	the T.A.P.
T361	DemonstrativeNP 9032 9046	these patients
T362	ZeroArticleNP 8979 8994	drug initiation
T363	IndefiniteNP 9197 9225	a known clinical consequence
T364	IndefiniteNP 9263 9277	a known effect
T365	IndefiniteNP 9294 9331	other endothelin receptor antagonists
T366	IndefiniteNP 9687 9715	a diuretic, fluid management
T367	DefiniteNP 9915 9924	the cause
T368	DefiniteNP 9976 9993	the possible need
T369	DefiniteNP 10184 10199	the possibility
T370	IndefiniteNP 10454 10491	other endothelin receptor antagonists
T371	IndefiniteNP 10502 10519	an adverse effect
T372	IndefiniteNP 10678 10701	a dose-related decrease
T373	PersonalPronoun 10878 10880	It
T374	DefiniteNP 11101 11110	the cause
T375	IndefiniteNP 10994 11011	a marked decrease
T376	IndefiniteNP 11318 11349	other CYP3A-metabolized statins
T377	ZeroArticleNP 11351 11366	Combination use
T378	ZeroArticleNP 11377 11392	statin exposure
T379	DefiniteNP 11661 11685	the plasma concentration
T380	DemonstrativeNP 11634 11647	these enzymes
T381	IndefiniteNP 11753 11771	a CYP2C9 inhibitor
T382	IndefiniteNP 11812 11836	a strong CYP3A inhibitor
T383	IndefiniteNP 11875 11901	a moderate CYP3A inhibitor
T384	IndefiniteNP 12088 12106	a CYP2C9 inhibitor
T385	IndefiniteNP 12112 12148	a strong or moderate CYP3A inhibitor
T386	DemonstrativeNP 12067 12084	such combinations
T387	IndefiniteNP 12195 12205	an inducer
T388	DemonstrativeNP 12265 12304	drugs metabolized by these two isozymes
T389	IndefiniteNP 12402 12417	any CYP isozyme
T390	DefiniteNP 12520 12545	the plasma concentrations
T391	DemonstrativeNP 12570 12583	these enzymes
T392	ZeroArticleNP 12549 12554	drugs
T393	IndefiniteNP 12927 12947	An interaction study
T394	IndefiniteNP 12999 13040	a combination oral hormonal contraceptive
T395	DefiniteNP 13263 13293	The concomitant administration
T396	DefiniteNP 13380 13393	the first day
T397	DefiniteNP 13492 13505	The mechanism
T398	DemonstrativeNP 13509 13525	this interaction
T399	DefiniteNP 13712 13723	the absence
T400	DefiniteNP 13782 13807	the plasma concentrations
T401	IndefiniteNP 13827 13844	a CYP3A substrate
T402	IndefiniteNP 13884 13901	An increased risk
T403	ZeroArticleNP 13973 13992	concomitant therapy
T404	DefiniteNP 14020 14050	the concomitant administration
T405	ZeroArticleNP 14101 14132	alternative hypoglycemic agents
T406	DefiniteNP 14222 14247	the plasma concentrations
T407	DefiniteNP 14283 14308	The plasma concentrations
T408	IndefiniteNP 14424 14508	other oral hypoglycemic agents that are predominantly metabolized by CYP2C9 or CYP3A
T409	DefiniteNP 14510 14525	The possibility
T410	DemonstrativeNP 14572 14584	these agents
T411	IndefiniteNP 14635 14674	Other Ritonavir-containing HIV Regimens
T412	DefiniteNP 14731 14766	the Organic Anion Transport Protein
T413	IndefiniteNP 14716 14727	a substrate
T414	PossessivePronoun 14942 14952	its effect
T415	DefiniteNP 14858 14868	the impact
T416	DefiniteNP 14885 14905	the pharmacokinetics
T417	DefiniteNP 15089 15114	the trough concentrations
T418	DefiniteNP 15274 15282	the dose
T419	DefiniteNP 15444 15464	the pharmacokinetics
T420	IndefiniteNP 15533 15546	Other Statins
T421	PossessivePronoun 15653 15692	its active beta-hydroxy acid metabolite
T422	DefiniteNP 15587 15612	the plasma concentrations
T423	IndefiniteNP 15629 15646	a CYP3A substrate
T424	DefiniteNP 15716 15741	The plasma concentrations
T425	IndefiniteNP 15834 15891	other statins that are significantly metabolized by CYP3A
T426	DefiniteNP 15930 15945	The possibility
T427	ZeroArticleNP 15949 15972	reduced statin efficacy
T428	DefiniteNP 16120 16135	the statin dose
T429	ZeroArticleNP 16010 16035	CYP3A-metabolized statins
T430	DefiniteNP 16299 16333	the first concomitant dose (likely
T431	IndefiniteNP 16244 16250	a mean
T432	IndefiniteNP 16384 16398	a 60% decrease
T433	DefiniteNP 16435 16445	The effect
T434	DefiniteNP 16522 16544	the potential benefits
T435	DefiniteNP 16643 16660	the first 4 weeks
T436	DefiniteNP 17109 17134	the plasma concentrations
T437	IndefiniteNP 17073 17097	a potent CYP3A inhibitor
T438	DefiniteNP 17400 17425	the plasma concentrations
T439	IndefiniteNP 17446 17464	a CYP2C9 substrate
T440	IndefiniteNP 17482 17499	a CYP3A substrate
T441	DefiniteNP 17742 17762	the clinical studies
T442	DefiniteNP 17769 17777	the need
T443	DefiniteNP 17788 17805	the warfarin dose
T444	DefiniteNP 17813 17823	the trials
T445	IndefiniteNP 18282 18293	a reduction
T446	DefiniteNP 18390 18401	The changes
T447	DefiniteNP 18566 18579	the treatment
T448	DemonstrativeNP 18507 18526	This recommendation
T449	DefiniteNP 18805 18817	the addition
T450	IndefiniteNP 18659 18666	a small
T451	DefiniteNP 18894 18908	The mean daily
T452	DefiniteNP 18937 18952	the mean number
